Cargando…
Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects
BACKGROUND: The PD-L1/PD-1 pathway blockade-mediated immune therapy has shown promising efficacy in the treatment of multiple cancers including melanoma. The present study investigated the effects of the flavonoid apigenin on the PD-L1 expression and the tumorigenesis of melanoma. METHODS: The influ...
Autores principales: | Xu, Lu, Zhang, Yang, Tian, Kang, Chen, Xi, Zhang, Rongxin, Mu, Xindi, Wu, Yueguang, Wang, Duchuang, Wang, Shanshan, Liu, Fang, Wang, Taishu, Zhang, Jinrui, Liu, Shuyan, Zhang, Yingqiu, Tu, Caixia, Liu, Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206930/ https://www.ncbi.nlm.nih.gov/pubmed/30373602 http://dx.doi.org/10.1186/s13046-018-0929-6 |
Ejemplares similares
-
The exon 19-deleted EGFR undergoes ubiquitylation-mediated endocytic degradation via dynamin activity-dependent and -independent mechanisms
por: Wang, Taishu, et al.
Publicado: (2018) -
Cholesterol content in cell membrane maintains surface levels of ErbB2 and confers a therapeutic vulnerability in ErbB2-positive breast cancer
por: Zhang, Jinrui, et al.
Publicado: (2019) -
USP29 enhances chemotherapy-induced stemness in non-small cell lung cancer via stabilizing Snail1 in response to oxidative stress
por: Wu, Yueguang, et al.
Publicado: (2020) -
The deubiquitylase USP2 maintains ErbB2 abundance via counteracting endocytic degradation and represents a therapeutic target in ErbB2-positive breast cancer
por: Zhang, Jinrui, et al.
Publicado: (2020) -
USP42 drives nuclear speckle mRNA splicing via directing dynamic phase separation to promote tumorigenesis
por: Liu, Shuyan, et al.
Publicado: (2021)